Glucagon-like peptide-1, or GLP-1, is a natural incretin hormone that is produced by the gut and helps the body to perform metabolism (breakdown and synthesis of chemical substances)
Our healthcare providers are here to discuss the potential benefits and costs of GLP-1 treatments and assist you in navigating insurance and financial assistance programs
It is exclusively prepared for patients with clinical needs that cannot be met by commercially available alternatives and is not for resale, bulk distribution, or office use
Peer-reviewed research isnt infallible, but its subjected to scientific scrutiny that social media posts arent
(Source: lan Clinic, June 2026) Relative Risk Compared to Placebo A systematic review published in the Journal of Clinical Investigation quantified the increased nausea risk for each newer-generation therapy against placebo: Worth noting: Semaglutide and tirzepatide show nearly identical nausea risk 2.95 versus 2.90 relative to placebo
Book your consultation today
